Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
3
394800
vs
K
KOSPI 200
Over the past 12 months, 3Billion Inc has underperformed KOSPI 200, delivering a return of -22% compared to KOSPI 200's +119% growth.
Stocks Performance
394800 vs KOSPI 200
Performance Gap
394800 vs KOSPI 200
Performance By Year
394800 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
3Billion Inc
Glance View
3Billion Inc is a South Korean genetic testing company focused on rare disease diagnosis. It analyzes DNA samples, especially whole-exome and whole-genome data, to help doctors find the genetic cause of hard-to-diagnose conditions. The company also builds software that helps interpret complex sequencing results, which is a key step in turning raw genetic data into a usable medical diagnosis. Its main customers are hospitals, clinical laboratories, physicians, and research partners that need help with genetic testing and variant interpretation. 3Billion makes money by selling diagnostic testing services, software tools, and related analysis work. In practice, it sits between sequencing labs that generate the data and clinicians who need clear answers for patients. What makes the business different is its focus on rare diseases, where diagnosis is often slow and difficult and each case can require deep analysis rather than a standard test. Instead of selling a broad menu of general lab services, it concentrates on one of the most specialized parts of genomics: finding meaning in complex genetic information and helping clinicians use that information in patient care.